Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH NIAID
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75N95024R00094 in this department, oldest first.
- Aug 5, 2026Award NoticeTCG INC · $49.7MOpen
- Aug 5, 2026 · this noticeAward NoticeCURIA GLOBAL INC · $49.7M
- Aug 5, 2026Award NoticeALCHEM LABORATORIES CORPORATION · $49.7MOpen
- Aug 5, 2026Award NoticeSOUTHWEST RESEARCH INSTITUTE San Antonio TX 78238 USA · $49.7MOpen
- Aug 5, 2026Award NoticeSIA PARTNERS U.S., INC. · $49.7MOpen
- Aug 17, 2026Award NoticeTCG GREENCHEM INC · $49.7MOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
A competitive multiple award, Indefinite Delivery/Indefinite Quantity (ID/IQ) type contract was awarded, with a ordering period (August 1, 2026 through May 14, 2031). It is anticipated that Task Orders issued against these contracts will most likely be cost-reimbursement, term/completion type Task Orders. Upon analysis of the type of work and all associated costs involved, fixed-price type task orders are usually not feasible due to the absence of precise specifications and difficulties in estimating costs with accuracy. Based upon the uncertainties involved, the Government would assume undue … (show all)
risk in attempting to fit relatively dynamic (science responsive and result-drive) requirement into a fixed-price environment. In these instances, fixed-price task orders would be disadvantageous to the Government, since they do not provide the Government with the flexibility that is needed to reasonably and responsively shift with the evolving needs of this requirement. However, fixed price Task Order may be issued, where appropriate and feasible. The Contractor is eligible for Task Orders under Technical Areas 1 and 3. The award notice is in relation to Solicitation # 75N95024R00094.
Who won similar work
10 award notices on SAM.gov in the last 24 months. Match: Same agency (National Institutes of Health), same industry group (NAICS 3254).
| Winner | Awards | Value | Last |
|---|---|---|---|
| SRI INTERNATIONAL Menlo Park CA 94025 USA | 2 | – + 2 shared | Jul 8, 2026 |
| BIOFIRE DEFENSE LLC | 1 | $1.7M | Jan 10, 2025 |
| VECTOR BIOMED INC. | 1 | $804K | Dec 2, 2024 |
| ALCHEM LABORATORIES CORPORATION | 1 | – + 1 shared | May 5, 2026 |
| MRIGLOBAL Kansas City MO 64110 USA | 1 | – + 1 shared | May 5, 2026 |
| MURTY PHARMACEUTICALS, INC. | 1 | – + 1 shared | Jul 8, 2026 |
| KYMANOX CORP | 1 | – + 1 shared | Jul 8, 2026 |
| CURIA GLOBAL INC | 1 | – + 1 shared | May 5, 2026 |
| EMINENT SERVICES CORP | 1 | – + 1 shared | Jul 8, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Jul 8, 2026EMINENT SERVICES CORP$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
- Jul 8, 2026KYMANOX CORP$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
- Jul 8, 2026MURTY PHARMACEUTICALS, INC.$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
- Jul 8, 2026SRI INTERNATIONAL Menlo Park CA 94025 USA$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
- May 5, 2026SRI INTERNATIONAL Menlo Park CA 94025 USA$50.0M (shared ceiling)A--Drug Manufacturing and Formulation Program (DMFP)
- May 5, 2026MRIGLOBAL Kansas City MO 64110 USA$50.0M (shared ceiling)A--Drug Manufacturing and Formulation Program (DMFP)
- May 5, 2026CURIA GLOBAL INC$50.0M (shared ceiling)A--Drug Manufacturing and Formulation Program (DMFP)
- May 5, 2026ALCHEM LABORATORIES CORPORATION$50.0M (shared ceiling)A--Drug Manufacturing and Formulation Program (DMFP)
- Jan 10, 2025BIOFIRE DEFENSE LLC$1.7MBioFire Reagents and Test Kits
- Dec 2, 2024VECTOR BIOMED INC.$804KServices for the Production and Stability Testing of Clinical Grade Lentiviral Vector
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.